SCHEMBL8408595

SCHEMBL8408595

C[Si](C)(C)OCCCCCl

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.35
ALDH1A1 P00352 2/20 0.35
TDP1 Q9NUW8 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14673800 0.97 TSHR (0.39) TSHRALDH1A1TDP1
SCHEMBL8741680 0.97 TSHR (0.39) TSHRALDH1A1TDP1
SCHEMBL9126036 0.97 TSHR (0.39) TSHRALDH1A1TDP1
SCHEMBL3056886 0.97 TSHR (0.39) TSHRALDH1A1TDP1
SCHEMBL31756933 0.97 TSHR (0.39) TSHRALDH1A1TDP1
SCHEMBL8438526 0.97 TSHR (0.39) TSHRALDH1A1TDP1
SCHEMBL531396 0.92
SCHEMBL823000 0.85
SCHEMBL20483089 0.82
SCHEMBL9284273 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113292589-B Method for tetrahydrofuran ring-opening double-silicification reaction 武汉大学 2022-08-30 CN disclosed
CN-113292589-A Method for tetrahydrofuran ring-opening double-silicification reaction 武汉大学 2021-08-24 CN disclosed
US-8936859-B2 Cyclophosphazene compound, lubricant comprising same, and magnetic disk MORESCO CORPORATION (JP) 2015-01-20 US disclosed
EP-2565198-B1 CYCLOPHOSPHAZENE COMPOUND, LUBRICANT COMPRISING SAME, AND MAGNETIC DISK MORESCO CORP (JP) 2014-09-10 EP disclosed
EP-2565198-A1 CYCLOPHOSPHAZENE COMPOUND, LUBRICANT COMPRISING SAME, AND MAGNETIC DISK MORESCO Corporation (JP) 2013-03-06 EP disclosed
US-20130034749-A1 CYCLOPHOSPHAZENE COMPOUND, LUBRICANT COMPRISING SAME, AND MAGNETIC DISK MORESCO CORPORATION (JP) 2013-02-07 US disclosed
US-5918641-A Flexible tubular conduit comprising a jacket made of crosslinked polyethylene device and process for manufacturing such a conduit HARDY JEAN (FR) 1999-07-06 US disclosed
US-5514312-A Process for manufacturing a flexible tubular conduit having a jacket made of crosslinked polyethylene COFLEXIP (FR) 1996-05-07 US disclosed
EP-0487691-B1 FLEXIBLE TUBULAR DUCT COMPRISING A CROSS-LINKED POLYETHYLENE SLEEVE, AND DEVICE AND METHOD FOR MANUFACTURING SAME COFLEXIP (FR) 1995-07-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130034749-A1 CYCLOPHOSPHAZENE COMPOUND, LUBRICANT COMPRISING SAME, AND MAGNETIC DISK FXR2, CYFIP2, F2 TSHR 2545/4885ALDH1A1 4257/4885TDP1 2445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.